Hypertension management in minority communities: A clinician survey

Journal of General Internal Medicine

Volumn 23, Issue 1, 2008, Pages 81-86

  Goldstein, Cheryl E ^a   Hebert, Paul L ^b   Sisk, Jane E ^b   McLaughlin, Mary Ann ^b   Horowitz, Carol R ^b   McGinn, Thomas G ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Clinician; Disparities; Hypertension; Quality of care; Survey

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; AMLODIPINE BESYLATE; ATENOLOL; ATORVASTATIN; HYDROCHLOROTHIAZIDE; LISINOPRIL; NIFEDIPINE; PARACETAMOL;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CAUCASIAN; CHRONIC KIDNEY FAILURE; COMORBIDITY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIABETES MELLITUS; DRUG DOSE INCREASE; ETHNIC GROUP; ETHNICITY; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEALTH PERSONNEL ATTITUDE; HEALTH SURVEY; HISPANIC; HUMAN; HYPERTENSION; KIDNEY DISEASE; MALE; MINORITY GROUP; PATIENT CARE; PHYSICIAN; PRACTICE GUIDELINE; PROFESSIONAL COMPETENCE; PROFESSIONAL PRACTICE; RACE DIFFERENCE; SEX DIFFERENCE; SOCIAL ASPECT; SYSTOLIC HYPERTENSION; UNITED STATES;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CLINICAL COMPETENCE; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; HEALTHCARE DISPARITIES; HUMANS; HYPERTENSION; MALE; MEDICAL STAFF, HOSPITAL; MINORITY GROUPS; NEW YORK CITY; OUTPATIENT CLINICS, HOSPITAL; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; URBAN POPULATION;

EID: 37749017877     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-007-0413-z     Document Type: Article

References (24)

1. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199-206.
2. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey 1988-1991. Hypertension. 1995;25:305-13.
3. Chobian AV, Bakris GL, Black HR, et al. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VII). JAMA. 2003;289:2560-72.
4. JNC 6. National High Blood Pressure Education Program. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-46.
5. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA. 1997;277:1293-8.
6. Stockwell DH, Madhavan S, Cohen H, Gibson G, Alderman MH. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health. 1994;84:1768-74.
7. Ahluwalia JS, McNagny SE, Rask KJ. Correlates of controlled hypertension in indigent, inner-city hypertensive patients. J Gen Intern Med. 1997;12:7-14.
8. Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000;160:2281-6.
9. Hyman DJ, Pavlik VN, Vallbona C. Physician role in lack of awareness and control of hypertension. J Clin Hypertens. 2000;2:324-30.
10. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med. 1993;153:154-83.
11. Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957-63.
12. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413-20.
13. Van Ryn M. Research on the provider contribution to race/ethnicity disparities in medical care. Med Care. 2002;40(Suppl 1):I-140-51.
14. Schulman KA, Berlin JA, Harless W, et al. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med. 1999;340:618-26.
15. Schwartz LM, Woloshin S, Welch HG. Misunderstandings about the effects of race and sex on physicians' referrals for cardiac catheterization. N Engl J Med. 1999;341:279-83.
16. Van Ryn M, Burke J. The effect of patient race and socio-economic status on physicians' perceptions of patients. Soc Sci Med. 2000;50:813-28.
17. Green BB, Kaplan RC, Psaty BM. How do minor changes in the definition of blood pressure control affect the reported success of hypertension treatment? Am J Manag Care. 2003;9:219-24.
18. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker or diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-97.
19. Swanson DB, Barrow HS, Friedman CP. Issues in assessment of clinical competence. Prof Educ Res. 1982;4:2.
20. Moskowitz AJ, Kuipers B, Kassirer JP. Dealing with uncetainty, risks, and trade offs in clinical decisions: a cognitive science approach. Ann Intern Med. 1988;108:435-49.
21. Jones TV, Gerrity MS, Earp J. Written case simulations: do they predict physicians' behavior? J Clin Epidemiol. 1990;43:805-15.
22. Kirwan JR, Chaput de Saintonge DM, Joyce CRB, Currey HLF. Clinical judgement in rheumatoid arthritis. I. Rheumatologists' opinions and the development of "paper patients." Ann Rheum Dis. 1983;42:644-7.
23. Kirwan JR, Bellamy N, Condon H, Buchanan WW, Barnes CG. Judging "current disease activity" in rheumatoid arthritis-an international comparison. J Rheumatol 1983;10:901-5.
24. U.S. Centers for Disease Control and Prevention. National diabetes fact sheet. http://www.cdc.gov/diabetes/pubs/estimates.htm, accessed September 2, 2005.